GlassScriptPhysician profile
Kaitlin M Zuber
NPI 1811419625
$11,324.39
in general payments reported to CMS, 2019-2025
36 companies · $2,763 in 2025
The $2,763 reported for 2025 was more than what 96% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,206 · 2022: $1,809 · 2023: $2,488 · 2024: $3,058 · 2025: $2,763.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,274 · Education: $35.27.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,273.73 |
| Education | $35.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $4,276.49 | 2021-2025 | Fasenra, Airsupra, Tezspire |
| Glaxosmithkline, LLC. | $2,069.25 | 2021-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Genzyme Corporation | $974.91 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $643.54 | 2021-2025 | Dupixent |
| Boehringer Ingelheim Pharmaceuticals, INC. | $432.12 | 2021-2025 | Spiriva Respimat, Stiolto Respimat, Ofev |
| Verona Pharma, INC. | $260.55 | 2025 | Ohtuvayre |
| Viatris Specialty LLC | $202.73 | 2025 | Yupelri |
| Abbvie INC. | $186.21 | 2024-2025 | |
| Actelion Pharmaceuticals US, INC. | $185.58 | 2021-2025 | Opsumit, Uptravi |
| Axsome Therapeutics, INC. | $173.63 | 2023-2024 | Sunosi |
| Mallinckrodt Hospital Products INC. | $173.32 | 2023-2024 | Acthar |
| Harmony Biosciences LLC | $166.34 | 2021-2025 | Wakix |
| Electromed, INC. | $162.28 | 2022-2025 | Smartvest |
| Amgen INC. | $131.46 | 2023-2024 | Tezspire |
| United Therapeutics Corporation | $127.08 | 2023-2025 | Tyvaso, Tyvaso |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $123.87 | 2024-2025 | Hillrom - Volara System, Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
| E.R. Squibb & Sons, L.L.C. | $94.66 | 2023-2024 | Eliquis, Camzyos |
| Takeda Pharmaceuticals U.S.A., INC. | $88.67 | 2022-2024 | Glassia, Takhzyro |
| Jazz Pharmaceuticals INC. | $87.35 | 2021-2023 | |
| Inspire Medical Systems, INC. | $86.29 | 2024-2025 | Inspire |
| Grifols USA, LLC | $82.67 | 2025 | Prolastin-C Liquid |
| Merck Sharp & Dohme LLC | $67.84 | 2025 | Winrevair |
| Ani Pharmaceuticals, INC. | $63.00 | 2025 | Purified Cortrophin Gel |
| Vifor Pharma, INC. | $52.56 | 2025 | Zemaira |
| Novartis Pharmaceuticals Corporation | $50.74 | 2023-2024 | |
| Advanced Respiratory, INC | $48.91 | 2021 | |
| Ars Pharmaceuticals Operations, INC. | $43.40 | 2025 | Neffy |
| Insmed, INC. | $42.70 | 2023-2024 | Arikayce |
| Mylan Specialty L.P. | $40.26 | 2022-2023 | Yupelri |
| Bayer Healthcare Pharmaceuticals INC. | $37.02 | 2023-2025 | |
| Resmed Corp | $35.27 | 2023 | |
| Inogen, INC. | $32.64 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Philips North America LLC | $29.15 | 2025 | Vest Therapy Und |
| Optinose US, INC. | $19.08 | 2025 | |
| Lilly USA, LLC | $17.34 | 2025 | Zepbound |
| Pfizer INC. | $15.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlin Zuber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.